Efficacy and Safety of the Aflibercept Biosimilar SB15 in Neovascular Age-Related Macular Degeneration

202331 citationsJournal Articlehybrid Open Access

Authors

ClinicalTrials.gov Identifier: NCT04450329.

Good health and well-being

Published in: JAMA Ophthalmology

Volume 141, Issue 7, pp. 668-668

Field-Weighted Citation Impact: 8.59